In our latest Trade to Black podcast we dive deeper into Canopy Growth’s stock performance that is continuously sinking as penny stocks and how this affect the overall health of the industry. Canopy was one of the leading pioneers in the space, but how did the company fall down deep and is this a sign that their era is ending or are we just waiting for regulations to save the space?
We also touch on Tilray’s market status and how their recent announcement on $150 million convertible notes and market bi-programs can be their downfall as this also reflects their negative cash position which is already a pain point to investors. We also talk about how management leadership affects a company’s future and if these drawbacks are hitting rock bottom.
Lastly we talk about the rising success of Numinus and its project rollouts as they started with trainings and certifications on psychedelic-assisted therapies and treatments. What could be the company’s outlook moving forward as it partnered with MAPS? Will they become the most awaited catalyst in the psychedelic industry?
Here’s the latest.
Time Stamps:
0:00 - 25:35 Canopy Sinks?
25:36 - 5:43 Investment Basis
5:44 - 8:20 Will It Sink or Swim?
8:21 - 10:32 What’s Next for Canopy?
10:33 - 11:56 Tilray’s Cash Negative!
11:57 - 14:44 Are ATM Programs Good?
14:45 - 16:19 Why CEO leadership Matters
16:20 - 17:38 Bruce Linton is the Real Pioneer
17:39 - 20:57 MindMed VS. FCS
20:58 - 22:44 Management’s Low Profile Share a Risk?
22:45 - 25:06 Numinus and MAPS Partnership
25:07 - 26:04 Best Colorado Dispensaries
26:05 - 27:44 Tech Rally Rises
27:28 - 28:34 Why Tech Will Always Be Bullish
28:35 - 30:54 Upcoming Rate Hikes?
Add us on:
LinkedIn [ Ссылка ]
TikTok: [ Ссылка ]
Instagram: [ Ссылка ]
Website: [ Ссылка ]
For copyright matters please get in touch with us at: sdales@thedalesreport.com
The Dales Report Inc. disclosure policy applies to this video: [ Ссылка ]
